SJ Medical
SJ Medical
Japan stands at the global forefront of cardiovascular medicine, driven by one of the world's most rapidly aging populations. The demand for Bioresorbable Vascular Scaffolds (BVS) in Japan has seen an exponential rise as clinicians move away from permanent metallic stents toward "leaving nothing behind." As a leading supplier, we recognize that the Japanese market is defined by its rigorous PMDA (Pharmaceuticals and Medical Devices Agency) standards and a deep-rooted culture of Monozukuri—the art of making things with precision.
Currently, the industrial status of BVS in Japan is focused on minimizing "late-stage luminal loss" and reducing the risk of very late scaffold thrombosis. Our manufacturing protocols align with these local needs, providing PLLA (Poly-L-Lactic Acid) based solutions that provide temporary support to the vessel wall before being safely absorbed by the body, allowing the artery to regain its natural vasomotion.
Japan's R&D is currently exploring hybrid scaffolds that combine metallic elements with bioresorbable polymers to offer the strength of chrome-cobalt with the benefits of resorption.
With the high prevalence of complex calcified lesions in Japanese patients, delivery systems must be ultra-low profile with enhanced pushability and crossability.
The use of IVUS and OCT imaging during BVS implantation is a standard "localized scenario" in Japan to ensure perfect apposition and sizing.
Hangzhou SJ Medical Co., Ltd., established in 2015, is a pioneer in the research, development, and commercialization of vascular interventional medical devices. Our focus on both cardiovascular and peripheral intervention fields allows us to provide innovative, safe, and reliable solutions to healthcare providers in Japan and across the globe.
Our commitment to excellence is reflected in our 5,000-square-meter modern manufacturing facility, built to GMP standards. We operate a million-class clean workshop with localized hundred-class areas for critical processes, ensuring that every bioresorbable scaffold meets the stringent purity levels required for surgical implantation.
Supported by a technical team with decades of industry experience, we specialize in:
Sqm Facility
Certified Quality
To serve the Japanese market effectively, SJ Medical maintains international quality benchmarks. We have secured CE certification, ISO 13485, and CFDA approval. Our products are already making an impact in Europe (Italy, Spain, France) and Asia (India, Indonesia), proving our reliability as a global partner.
Whether you are a hospital procurement officer in Osaka or a research scientist in Nagoya, SJ Medical provides the expertise and precision required for the next generation of bioresorbable technology.
